Rosuvastatin Completed Phase 2 Trials for Dyslipidemias Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01105975A Study of LY2484595 in Patients With High LDL-C or Low HDL-C
NCT01970215TA-8995: Its Use in Patients With Mild Dyslipidaemia (TULIP)